ASHP Guidelines on Emergency Medicine Pharmacist Services

Ortmann, Melinda J.; Johnson, Elizabeth Giesler; Jarrell, Daniel H.; Bilhimer, Matt; Hayes, Bryan D.; Mishler, Aimee; Pugliese, Robert; Roberson, Taylor; Slocum, Giles W.; Smith, Andrew Paul; Yabut, Katie; Zimmerman, David E.

doi:10.1093/ajhp/zxaa378

Cited by 47 publications

(23 citation statements)

References 128 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…25,26 Examples provided in Table 3 are not all-encompassing, are not implied as the most critical or important, and are not intended to supplant previously created collections of activities and measures within specialty areas of practice. 3,4,23,27 For context, the term medication therapy problem (MTP) is defined as an event or circumstance involving pharmacotherapy that interferes with optimal patient care. 28 Further classifications and subclassifications of MTPs are presented in Figure 2.…”

Section: Proposed Quality Measures and Performance Indicators In Inpatient/ Acute Care Clinical Pharmacy Practicementioning

confidence: 99%

“…22 Reasons for this vari- with the goal of achieving standardization. 3,4,23,38,41,42 However, much work still needs to be done to implement clinical pharmacy practice standardization within and between institutions and organizations.…”

Section: Standardization Of Clinical Pharmacy Practice In the Inpatient/ Acute Care Setting For Achieving Optimal Quality And Performancementioning

confidence: 99%

“…Although a reduction in indirect costs or cost avoidance may result from the prevention of adverse drug events in some cases, cost was only mapped to the core quality measure if it was associated with a reduction in direct costs 25,26 . Examples provided in Table 3 are not all‐encompassing, are not implied as the most critical or important, and are not intended to supplant previously created collections of activities and measures within specialty areas of practice 3,4,23,27 …”

Section: Proposed Quality Measures and Performance Indicators In Inpatient/acute Care Clinical Pharmacy Practicementioning

confidence: 99%

“…In recent years, health care has been evolving from a fee‐for‐service to a value‐based care model, with large payers like the Centers for Medicare & Medicaid Services (CMS) placing greater emphasis on quality of care 1 . In this evolution, a focus has emerged on interprofessional team‐based care with clinical pharmacists increasingly integrated as essential members of the health care team in a variety of clinical disciplines 2‐6 . Similarly, within interprofessional teams and health systems, stakeholders increasingly expect pharmacists to be accountable for medication‐related outcomes and the medication use system through the provision of clinical pharmacy services, including comprehensive medication management (CMM).…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Development and application of quality measures of clinical pharmacist services provided in inpatient/acute care settings

Acquisto

Beavers

Bolesta

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

As health care transitions to value-based care, it is more critical than ever to emphasize and quantify the impact on patient outcomes made by inpatient/acute care pharmacists and pharmacist extenders as members of the interprofessional care team.Thus, the American College of Clinical Pharmacy (ACCP) took to task the development of quality measures that were broadly applicable to the diverse inpatient/acute care landscape and important for standardizing practice, measuring impact, contextualizing benefit within the health care landscape, and allowing benchmarking within and between institutions. A framework was established by the writing committee of this paper in order to develop quality measures in a methodical manner. The resulting process led the writing committee to devise 31 foundational quality measures to be used in efforts to champion the pharmacist's role in achieving the quadruple aims in health care. Application and evaluation of quality measure performance as well as limitations and future implications of the measures are addressed to further highlight the evolving role of the inpatient/acute care pharmacist and pharmacist extender.

show abstract

Section: Proposed Quality Measures and Performance Indicators In Inpatient/ Acute Care Clinical Pharmacy Practicementioning

confidence: 99%

Section: Standardization Of Clinical Pharmacy Practice In the Inpatient/ Acute Care Setting For Achieving Optimal Quality And Performancementioning

confidence: 99%

Section: Proposed Quality Measures and Performance Indicators In Inpatient/acute Care Clinical Pharmacy Practicementioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Development and application of quality measures of clinical pharmacist services provided in inpatient/acute care settings

Acquisto

Beavers

Bolesta

et al. 2021

J Am Coll Clin Pharm

View full text Add to dashboard Cite

show abstract

“…Pharmacists serve many important roles within the emergency department (ED) and their presence is recommended by numerous organisations 1–5 . Emergency medicine (EM) pharmacists serve as part of a multidisciplinary EM team to assist in caring for patients by participating in patient care decisions and ensuring safe, effective pharmacotherapy, among numerous other roles.…”

Section: Introductionmentioning

confidence: 99%

Effect of pharmacist education and intervention on ketorolac prescribing in an emergency department

O’Brien

Fuh

White

et al. 2021

Pharmacy Practice and Res

View full text Add to dashboard Cite

Background Pharmacists serve many important roles within the emergency department (ED) and frequently provide education on medications to clinicians and patients. Following a study that demonstrated a potential “analgesic ceiling” effect with ketorolac and suggested that doses lower than 30 mg IV may be effective, we implemented a reduced‐dose ketorolac pathway in our institution’s ED. Aim To assess the impact pharmacist education and on‐shift, active interventions had on ED clinicians' IV ketorolac prescribing habits. Method This was a retrospective, quasi‐experimental study conducted to evaluate the effect of a brief pharmacist‐led educational email intervention on ketorolac prescribing habits within an ED at a large, academic medical center. All orders of IV ketorolac for adult patients in the ED 180 days prior to and following the educational email were included in the analysis. Results Prior to the educational effort, 30 mg IV doses of ketorolac were most frequently ordered (n = 1772). However, following the educational effort, significantly fewer orders were for the 30 mg dose (n = 718) and the majority of orders were for 15 mg IV (n = 2081; p < 0.00001), consistent with the teaching from the intervention. Conclusion In this study, a significant prescribing practice change was facilitated by pharmacist‐led email education supported by on‐shift active guidance for clinicians by pharmacists.

show abstract

Survey of national practices for postgraduate year two critical care and emergency medicine pharmacy residency emergency response training

Philips

Cycz

Liu

et al. 2023

J Am Coll Clin Pharm

View full text Add to dashboard Cite

IntroductionMedical emergency response within the hospital involves an interdisciplinary team, including pharmacists. Pharmacist involvement in these teams has increased over time due to published benefits of their involvement. Development of emergency response skills may start during pharmacy residency, although limited data suggest how this is best implemented.ObjectivesLimited data evaluate post‐graduate year 2 (PGY2) pharmacy resident training for emergency response, as well as PGY2 program values for this in screening/ranking candidates, which may help post‐graduate year one (PGY1) pharmacy residents identify residency programs that are a good fit for their career goals.MethodsA list of PGY2 critical care (CC) and emergency medicine (EM) programs were identified. The questionnaire included program demographics, characteristics of PGY2 emergency response training, and PGY2 residency program values of PGY1 emergency response exposure for screening and ranking applicants for their programs. A Fisher's exact test was used to compare differences between CC and EM programs for these outcomes.ResultsA total of 85 complete responses were analyzed (response rate by all identified programs: CC = 36.4%; EM = 32.1%). Emergency response training was often with both core and longitudinal experiences (72.9%), although differed by type of program (p < 0.001). Both CC and EM programs considered PGY1 pharmacy resident exposure to emergency response in screening candidates (33.9% and 57.7%, respectively), as well as ranking candidates (22% and 38.5%, respectively). For CC programs, both Advanced Cardiovascular Life Support certification and quantity of PGY1 emergency response ranked as the most important characteristics, while EM programs ranked quantity as the most important.ConclusionThe results of this survey indicate heterogeneity in PGY2 CC and EM emergency response training. PGY1 applicants for these programs should consider their experience with emergency response as a potential factor in identifying an appropriate program for their training.

show abstract

ASHP Guidelines on Emergency Medicine Pharmacist Services

Cited by 47 publications

References 128 publications

Development and application of quality measures of clinical pharmacist services provided in inpatient/acute care settings

Development and application of quality measures of clinical pharmacist services provided in inpatient/acute care settings

Effect of pharmacist education and intervention on ketorolac prescribing in an emergency department

Survey of national practices for postgraduate year two critical care and emergency medicine pharmacy residency emergency response training

Contact Info

Product

Resources

About